Boston Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 4

Boston Therapeutics General Information

Description

Nanomix Corp is the leader in the development of mobile point-of-care (POC) diagnostics, with a handheld testing platform and assays that provide rapid, accurate, quantitative information for use in settings where time is critical for clinical decision-making and improved patient care.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 354 Merrimack Street
  • Suite 4
  • Lawrence, MA 01843
  • United States
Primary Industry
Pharmaceuticals
Acquirer
Former Stock Listing
NNMX
Corporate Office
  • 354 Merrimack Street
  • Suite 4
  • Lawrence, MA 01843
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boston Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boston Therapeutics‘s full profile, request access.

Request a free trial

Boston Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nanomix Corp is the leader in the development of mobile point-of-care (POC) diagnostics, with a handheld testing platfor
Pharmaceuticals
Lawrence, MA
1 As of 2018

Vienna, Austria
 

Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Boston Therapeutics Competitors (29)

One of Boston Therapeutics’s 29 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY
Evonile Pharma Private Equity-Backed Mumbai, India
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
You’re viewing 5 of 29 competitors. Get the full list »

Boston Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boston Therapeutics Acquisitions (4)

Boston Therapeutics’s most recent deal was a Reverse Merger with Nanomix. The deal was made on 04-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nanomix 04-Jun-2021 Reverse Merger Diagnostic Equipment
Medical Technology Associates II 11-Apr-2018 Merger/Acquisition Other Pharmaceuticals and Biotechnology
CureDM 12-Feb-2018 Merger/Acquisition Drug Discovery
Avanyx Therapeutics 20-Nov-2010 Merger/Acquisition Drug Discovery
To view Boston Therapeutics’s complete acquisitions history, request access »

Boston Therapeutics FAQs

  • When was Boston Therapeutics founded?

    Boston Therapeutics was founded in 2009.

  • Where is Boston Therapeutics headquartered?

    Boston Therapeutics is headquartered in Lawrence, MA.

  • What is the size of Boston Therapeutics?

    Boston Therapeutics has 1 total employees.

  • What industry is Boston Therapeutics in?

    Boston Therapeutics’s primary industry is Pharmaceuticals.

  • Is Boston Therapeutics a private or public company?

    Boston Therapeutics is a Private company.

  • What is Boston Therapeutics’s current revenue?

    The current revenue for Boston Therapeutics is .

  • How much funding has Boston Therapeutics raised over time?

    Boston Therapeutics has raised $20.8M.

  • Who are Boston Therapeutics’s competitors?

    Pfizer (Vienna), Pfizer Pakistan, Regeneron Pharmaceuticals, Evonile Pharma, and Gesynta Pharma are some of the 29 competitors of Boston Therapeutics.

  • When was Boston Therapeutics acquired?

    Boston Therapeutics was acquired on 04-Jun-2021.

  • Who acquired Boston Therapeutics?

    Boston Therapeutics was acquired by Nanomix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process